phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertelsen, CV; Cornea, A; Frazier, SED; Gerstenberg, MK; Guldbrandt, M; Hansen, AMK; John, LM; Lundh, S; Lykkesfeldt, J; Mercer, AJ; Niss, K; Petersen, N; Quintana, CD; Rekling, JC; Torz, L; Villaescusa, JC | 1 |
| Quillet, R; Simonin, F | 1 |
2 other study(ies) available for phenylalanyl-leucyl-phenylalanyl-glutaminyl-prolyl-glutaminyl-arginyl-phenylalaninamide and Obesity
| Article | Year |
|---|---|
NPFF Decreases Activity of Human Arcuate NPY Neurons: A Study in Embryonic-Stem-Cell-Derived Model.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Humans; Neurons; Neuropeptide Y; Obesity; Oligopeptides | 2022 |
[The neuropeptide FF: a signal for M1 to M2 type switching in macrophages from the adipose tissue].
Topics: Adipose Tissue; Animals; Humans; Inflammation; Macrophages; Mice; Obesity; Oligopeptides; Signal Transduction | 2018 |